Brind.

Cathie Wood invested in Intellia Therapeutics, a company based in Cambridge, Massachusetts.

4 reports, 2 independent Updated Jul 1

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 4
Developments: 1
Repetition: 75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Cathie Wood invested in Intellia Therapeutics, a company based in Cambridge, Massachusetts.

Who's involved

What this event is mainly about

Intellia Therapeutics Cathie Wood

Keep exploring

The entities involved

Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.

Nothing else this week.
Cathie Wood
American investor and businesswoman; CEO of Ark Invest
- Cathie Wood predicts that Bitcoin's price will reach $2.4 million by 2030.Sun 04:13
- Cathie Wood's firm, ARK, sold shares of AMD while simultaneously buying shares of Nvidia during August 2024.Fri 06:52

Related events

Intellia Therapeutics announced it will present at a conference on September 4, 2026.Sep 4

Coverage

Newest first; wire copies grouped

Aug 21BarchartCathie Wood Is Betting Big on Intellia Therapeutics. Should You Buy NTLA Stock Here? Disruptive innovation investor Cathie Wood recently invested in clinical-stage biotech company Intellia Therapeuti
Aug 1GlobeNewswireIntellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-
Jul 8Unknown outlet

1 more outlet ran the same wire story

Jul 1manilatimes.net